scholarly journals ASCO Task Force on the Cost of Cancer Care

2009 ◽  
Vol 5 (5) ◽  
pp. 218-219 ◽  
Author(s):  
Lowell E. Schnipper
Keyword(s):  
United States ◽  
Cancer Care ◽  
Health Reform ◽  
Task Force ◽  
The United States ◽  
The World ◽  
Care Outcomes ◽  
The Cost

The United States leads the world in cancer care outcomes, but the cost is extremely high—and growing rapidly. New proposals for health reform emphasize one clear and immediate need: to control runaway cost.

scholarly journals The Effect of Massachusetts' Health Reform on Employer-Sponsored Insurance Premiums

2010 ◽  
Vol 13 (2) ◽  
Author(s):  
John F Cogan ◽  
R. Glenn Hubbard ◽  
Daniel Kessler
Keyword(s):  
United States ◽  
Health Reform ◽  
Medical Expenditure Panel Survey ◽  
Private Insurance ◽  
The United States ◽  
Medical Expenditure ◽  
Insurance Premiums ◽  
Reform Plan ◽  
The Difference ◽  
The Cost

In this paper, we use publicly available data from the Medical Expenditure Panel Survey - Insurance Component (MEPS-IC) to investigate the effect of Massachusetts' health reform plan on employer-sponsored insurance premiums. We tabulate premium growth for private-sector employers in Massachusetts and the United States as a whole for 2004 - 2008. We estimate the effect of the plan as the difference in premium growth between Massachusetts and the United States between 2006 and 2008—that is, before versus after the plan—over and above the difference in premium growth for 2004 to 2006. We find that health reform in Massachusetts increased single-coverage employer-sponsored insurance premiums by about 6 percent, or $262. Although our research design has important limitations, it does suggest that policy makers should be concerned about the consequences of health reform for the cost of private insurance.

scholarly journals Projections of the Cost of Cancer Care in the United States: 2010-2020

2011 ◽  
Vol 103 (2) ◽  
pp. 117-128 ◽  
Author(s):  
A. B. Mariotto ◽  
K. Robin Yabroff ◽  
Y. Shao ◽  
E. J. Feuer ◽  
M. L. Brown
Keyword(s):  
United States ◽  
Cancer Care ◽  
The United States ◽  
The Cost

American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care

2009 ◽  
Vol 27 (23) ◽  
pp. 3868-3874 ◽  
Author(s):  
Neal J. Meropol ◽  
Deborah Schrag ◽  
Thomas J. Smith ◽  
Therese M. Mulvey ◽  
Robert M. Langdon ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
Clinical Oncology ◽  
Cancer Care ◽  
Cost Effective ◽  
The United States ◽  
Cost Of Care ◽  
High Quality ◽  
American Society ◽  
The Cost

Advances in early detection, prevention, and treatment have resulted in consistently falling cancer death rates in the United States. In parallel with these advances have come significant increases in the cost of cancer care. It is well established that the cost of health care (including cancer care) in the United States is growing more rapidly than the overall economy. In part, this is a result of the prices and rapid uptake of new agents and other technologies, including advances in imaging and therapeutic radiology. Conventional understanding suggests that high prices may reflect the costs and risks associated with the development, production, and marketing of new drugs and technologies, many of which are valued highly by physicians, patients, and payers. The increasing cost of cancer care impacts many stakeholders who play a role in a complex health care system. Our patients are the most vulnerable because they often experience uneven insurance coverage, leading to financial strain or even ruin. Other key groups include pharmaceutical manufacturers that pass along research, development, and marketing costs to the consumer; providers of cancer care who dispense increasingly expensive drugs and technologies; and the insurance industry, which ultimately passes costs to consumers. Increasingly, the economic burden of health care in general, and high-quality cancer care in particular, will be less and less affordable for an increasing number of Americans unless steps are taken to curb current trends. The American Society of Clinical Oncology (ASCO) is committed to improving cancer prevention, diagnosis, and treatment and eliminating disparities in cancer care through support of evidence-based and cost-effective practices. To address this goal, ASCO established a Cost of Care Task Force, which has developed this Guidance Statement on the Cost of Cancer Care. This Guidance Statement provides a concise overview of the economic issues facing stakeholders in the cancer community. It also recommends that the following steps be taken to address immediate needs: recognition that patient-physician discussions regarding the cost of care are an important component of high-quality care; the design of educational and support tools for oncology providers to promote effective communication about costs with patients; and the development of resources to help educate patients about the high cost of cancer care to help guide their decision making regarding treatment options. Looking to the future, this Guidance Statement also recommends that ASCO develop policy positions to address the underlying factors contributing to the increased cost of cancer care. Doing so will require a clear understanding of the factors that drive these costs, as well as potential modifications to the current cancer care system to ensure that all Americans have access to high-quality, cost-effective care.

Michaels Craft Stores: Integrated Channel Management and Vendor-Retailer Relations

2017 ◽  
pp. 1-18
Author(s):  
Anne Coughlan ◽  
Lindsey M. Piegza
Keyword(s):  
United States ◽  
Supply Chain ◽  
State Of The Art ◽  
The United States ◽  
Arts And Crafts ◽  
Channel Management ◽  
Art Practices ◽  
The World ◽  
Training Courses ◽  
The Cost

Michaels Craft Stores is the largest arts and crafts retailer in the United States and in the world. Its CEO, Michael Rouleau, wants to expand the chain to 1,000 stores by 2006. The key constraint is the lack of sophistication among Michaels' supplier base, which is made up of over 1,000 suppliers, many of which are small, creative companies with little computer or logistics knowledge. As a result, the cost of running Michaels' supply chain is high. Describes the company's efforts to build the sophistication of its suppliers through educational Vendor Flow Training courses that teach suppliers how to adopt state-of-the-art practices for improved efficiency in supplying their channel.

Report of the Task Force on Pertussis and Pertussis Immunization—1988

PEDIATRICS ◽  
1988 ◽  
Vol 81 (6) ◽  
pp. 933-984 ◽  
Author(s):  
James D. Cherry ◽  
Philip A. Brunell ◽  
Gerald S. Golden ◽  
David T. Karzon
Keyword(s):  
United States ◽  
Pertussis Vaccine ◽  
Whooping Cough ◽  
Task Force ◽  
The United States ◽  
World Health ◽  
Epidemic Disease ◽  
The World ◽  
Mass Immunization ◽  
Health Organization

Pertussis (whooping cough) is an endemic and epidemic disease due to Bordetella pertussis. The disease has been and still is a major cause of morbidity and mortality in young children throughout the world. The World Health Organization estimates that 600,000 deaths due to pertussis occur yearly; virtually all of these deaths occurred in unimmunized infants.1 In the United States, pertussis has been successfully controlled by the routine mass immunization of infants and children. In the prevaccine era, there were 115,000 to 270,000 cases of pertussis and 5,000 to 10,000 deaths due to the disease each year.2 During the last 10 years, there have been 1,200 to 4,000 cases and five to ten deaths per year.3-6 Unfortunately, the control of pertussis by immunization has not enjoyed sustained international success because of controversy relating to vaccine reactions and effectiveness. Since 1982 this controversy has been a problem in the United States. Most pediatricians as well as a large number of parents are aware of the present pertussis vaccine controversy; however, few understand the facts. This controversy involving the media, political and legal sectors, and the scientific community is a major threat to our present immunization program and the future control of pertussis in the United States7-11 ("20/20," ABC News, Feb 5, 1985; "DPT: Vaccine Roulette," National Broadcasting Co, Date, 1982; Democrat and Chronicle, Rochester, NY, March 8-12, 1987, p 1; The Fresno Bee, Dec 2-3, 1984, p 1; Dec 5, 1987, p B14). Because of this, a task force on pertussis and pertussis vaccine was created by the Executive Board of the American Academy of Pediatrics to review the problem.

scholarly journals The Economic Impact of Terrorism from 2000 to 2018

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Harrison Bardwell ◽  
Mohib Iqbal
Keyword(s):  
United States ◽  
Economic Impact ◽  
World Economy ◽  
Cost Accounting ◽  
The United States ◽  
September 11 ◽  
Property Damage ◽  
The World ◽  
Global Terrorism ◽  
The Cost

Abstract This paper estimates the economic impact of terrorism at $US 33 billion in 2018. In the 18 years from 2000 to 2018, terrorism cost the world economy $US 855 billion. This model follows the methodology of the 2019 Global Terrorism Index and uses a bottom-up cost accounting approach to aggregate the cost of four indicators that result from the incidents of terrorism. The four indicators include terrorism-related deaths, injuries, property damage and GDP losses. The findings of this paper show that global terrorism peaked in 2014 with 33,555 deaths globally and a consequential economic impact of $US 111 billion. From 2011 to 2014, terrorism-related deaths increased by 353%, and terrorist incidents rose by 190%. The 100 incidents with the highest economic impact from deaths and injuries are included in the analysis. The September 11, 2001 attacks in the United States stands as the incident with the highest economic impact accounting for deaths and injuries only at $US 40.6 billion, this is followed by the Sinjar massacre in Sinjar, Nineveh, Iraq at $US 4.3 billion.

Sex Differences in Mass Media Preferences Across Four Asian Countries

2011 ◽  
Vol 23 (4) ◽  
pp. 186-191 ◽  
Author(s):  
Malini Ratnasingam ◽  
Lee Ellis
Keyword(s):  
United States ◽  
Sex Differences ◽  
Mass Media ◽  
The United States ◽  
Female Students ◽  
The Internet ◽  
Evolutionary Explanation ◽  
Asian Countries ◽  
The World ◽  
Media Preferences

Background. Nearly all of the research on sex differences in mass media utilization has been based on samples from the United States and a few other Western countries. Aim. The present study examines sex differences in mass media utilization in four Asian countries (Japan, Malaysia, South Korea, and Singapore). Methods. College students self-reported the frequency with which they accessed the following five mass media outlets: television dramas, televised news and documentaries, music, newspapers and magazines, and the Internet. Results. Two significant sex differences were found when participants from the four countries were considered as a whole: Women watched television dramas more than did men; and in Japan, female students listened to music more than did their male counterparts. Limitations. A wider array of mass media outlets could have been explored. Conclusions. Findings were largely consistent with results from studies conducted elsewhere in the world, particularly regarding sex differences in television drama viewing. A neurohormonal evolutionary explanation is offered for the basic findings.

Sign in / Sign up

Export Citation Format

Share Document